Revolutionizing treatment of neurodegenerative diseases - One patient at a time
Neurodegenerative diseases such as Alzheimer's and Parkinson's occur when nerve cells of the brain or the peripheral nervous system begin losing function and eventually die. Although the underlying causes are not fully understood, they include old age and genetic disorders. While advancements in medical treatment have shown some benefits, Houston-based Coya Therapeutics has obtained some promising early results when using Regulatory T-cells as a treatment option.
Regulatory T cells (Tregs) are a subgroup of T cells that act to suppress the immune response, maintaining homeostasis and self-tolerance. It has been shown that Tregs can inhibit T-cell proliferation and that dysregulation in Treg cell frequency or function may lead to the development of inflammatory disease. Therapeutical Treg modulation is also considered to be a promising approach to the treatment of some inflammatory disorders.